MK-2894 is a potent, selective, orally active, high-affinity (Ki = 0.56 nM) antagonist of the prostaglandin E receptor 4 (EP4 receptor) (IC50 = 2.5 nM); it exhibits strong anti-inflammatory activity in animal models of pain and inflammation and is useful for the study of arthritis.